Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Gemcitabine vs Sterile Water Irrigation to Prevent Bladder Cancer Implantation in UTUC
NCT04865939Phase 3Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2021
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in upper tract urothelial carcinoma (UTUC), sponsored by UT Southwestern Medical Center. Started Nov 2021; status: recruiting.
02
Drugs
gemcitabine
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT04865939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865939.